Case File №
#VI-2026-0905
Alpha-Gen
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
45 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Semaglutide | B Good | 5 | 6.8 | 5.4 | 7.6 | 24 Apr 2025 |
| Tirzepatide | B Good | 5 | 6.6 | 5.5 | 7.0 | 24 Apr 2025 |
| BPC-157 | C Okay | 5 | 5.5 | 4.6 | 6.4 | 24 Apr 2025 |
| Retatrutide | D Poor | 5 | 6.2 | 4.0 | 7.8 | 24 Apr 2025 |
| CJC-1295 | D Poor | 5 | 4.9 | 3.6 | 6.6 | 24 Apr 2025 |
| Ipamorelin | E Bad | 5 | 5.8 | 1.9 | 7.2 | 24 Apr 2025 |
| 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | X N/A | 2 | 5.8 | 4.1 | 7.4 | 26 Jan 2026 |
| ACE-031 | X N/A | 2 | 5.5 | 5.5 | 5.6 | 25 May 2026 |
| Aromasin (Exemestane) | X N/A | 2 | 6.4 | 5.2 | 7.6 | 19 Jan 2026 |
| BAC Water | X N/A | 3 | 6.8 | 6.1 | 7.6 | 17 May 2026 |
| BMK methyl glycidate CAS 80532-66-7 | X N/A | 2 | 6.0 | 5.5 | 6.4 | 26 Jan 2026 |
| Boldenone Cypionate | X N/A | 3 | 5.9 | 5.0 | 7.3 | 23 May 2026 |
| Botulinum toxin | X N/A | 1 | 6.0 | 6.0 | 6.0 | 13 Jun 2025 |
| Cerebrolysin | X N/A | 2 | 4.7 | 3.6 | 5.8 | 21 May 2026 |
| CJC-1295 With DAC | X N/A | 1 | 7.6 | 7.6 | 7.6 | 8 Jul 2025 |
| Cortagen | X N/A | 2 | 5.2 | 4.5 | 5.8 | 24 May 2026 |
| DNP | X N/A | 2 | 6.5 | 6.0 | 7.0 | 17 May 2026 |
| EPO | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 3 | 7.9 | 6.3 | 9.3 | 24 May 2026 |
| GHRP-6 Acetate | X N/A | 3 | 6.4 | 5.8 | 6.9 | 21 May 2026 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 5.8 | 5.8 | 5.8 | 7 May 2025 |
| GW-501516 (Cardarine) | X N/A | 3 | 6.0 | 5.3 | 6.7 | 26 Jan 2026 |
| HMG | X N/A | 2 | 7.0 | 6.4 | 7.6 | 26 Jan 2026 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 2 | 4.2 | 4.1 | 4.3 | 24 May 2026 |
| KPV Oral | X N/A | 2 | 6.1 | 3.7 | 8.4 | 26 Jan 2026 |
| Lipo-C FAT BLASTER | X N/A | 1 | 6.7 | 6.7 | 6.7 | 7 May 2025 |
| Methylene Blue | X N/A | 2 | 5.2 | 3.7 | 6.8 | 21 May 2026 |
| Metribolone | X N/A | 3 | 7.0 | 3.6 | 8.8 | 17 May 2026 |
| MOTS-C | X N/A | 2 | 6.5 | 6.4 | 6.5 | 19 Jan 2026 |
| MT-1 | X N/A | 3 | 6.9 | 6.4 | 7.5 | 26 Jan 2026 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 7.1 | 7.1 | 7.1 | 13 Jun 2025 |
| Nitroethane CAS 79-24-3 | X N/A | 1 | 7.4 | 7.4 | 7.4 | 11 Jun 2025 |
| Orforglipron | X N/A | 1 | 6.8 | 6.8 | 6.8 | 13 Jun 2025 |
| Ovagen | X N/A | 3 | 5.9 | 5.0 | 6.9 | 21 May 2026 |
| Primobolan E Raw | X N/A | 2 | 6.8 | 5.1 | 8.5 | 25 May 2026 |
| Prostamax | X N/A | 2 | 5.8 | 5.2 | 6.3 | 17 May 2026 |
| Proviron (Mesterolone) | X N/A | 3 | 5.7 | 4.1 | 6.5 | 17 May 2026 |
| S-23 Raw | X N/A | 3 | 6.6 | 5.4 | 8.2 | 26 Jan 2026 |
| Semaglutide Oral | X N/A | 2 | 5.9 | 5.3 | 6.5 | 25 May 2026 |
| Sustanon 400 | X N/A | 2 | 6.5 | 5.9 | 7.1 | 25 May 2026 |
| Tesofensine | X N/A | 3 | 5.6 | 5.0 | 6.2 | 21 May 2026 |
| Tren Hex | X N/A | 1 | 7.7 | 7.7 | 7.7 | 8 Jul 2025 |
| VIP | X N/A | 2 | 4.7 | 3.1 | 6.3 | 21 May 2026 |
| Winstrol Oil | X N/A | 3 | 6.4 | 5.6 | 7.7 | 24 May 2026 |
| YK11 | X N/A | 3 | 7.1 | 5.0 | 10.0 | 26 Jan 2026 |
Exhibit II
Evidence Log
89 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | BMK methyl glycidate CAS 80532-66-7 | 7.2 A | 5g | 5.3g | +5.6% | 97.00% | 27stx6 | Lab B | Community |
| 25 May 2026 | DNP | 6.9 A | 10mg | 8.6mg | -13.6% | 96.68% | eu1hsd | Lab F | Community |
| 25 May 2026 | KPV Oral | 4.0 C | 25mg | 29.0mg | +15.8% | 96.88% | buxp2q | Lab F | Public |
| 25 May 2026 | Metribolone | 5.7 B | 100mg/ml | 96.8mg/ml | -3.2% | 96.92% | 8u7rym | Lab G | Community |
| 25 May 2026 | Proviron (Mesterolone) | 4.0 C | 100mg | 90.2mg | -9.8% | 99.54% | 6375ta | Lab C | Public |
| 25 May 2026 | Tesofensine | 4.0 C | 10mg | 9.5mg | -5.2% | 96.35% | fshpos | Lab B | Public |
| 24 May 2026 | Botulinum toxin | 6.0 A | 10mg | 9.7mg | -2.8% | 97.54% | tfz7iu | Lab C | Community |
| 24 May 2026 | KPV Oral | 4.0 C | 100mg | 88.6mg | -11.4% | 96.36% | 9xib0b | Lab B | Community |
| 24 May 2026 | Sustanon 400 | 6.9 A | 200mg/ml | 246.0mg/ml | +23.0% | 97.88% | nvz31m | Lab D | Public |
| 24 May 2026 | VIP | 5.3 B | 50mg | 60.0mg | +20.1% | 97.32% | uvdzxr | Lab F | Public |
| 24 May 2026 | Cerebrolysin | 4.0 C | 50mg | 52.7mg | +5.3% | 99.20% | lrigje | Lab D | Public |
| 24 May 2026 | Prostamax | 5.7 B | 30mg | 33.6mg | +11.8% | 99.64% | z4soi2 | Lab G | Community |
| 24 May 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.3 B | 10g | 8.6g | -14.4% | 96.68% | 3ddoek | Lab D | Public |
| 24 May 2026 | Boldenone Cypionate | 7.7 A | 200mg/ml | 186.2mg/ml | -6.9% | 97.64% | rupmen | Lab F | Public |
| 24 May 2026 | DNP | 6.0 A | 10mg | 8.9mg | -10.6% | 98.79% | a9mlv9 | Lab F | Public |
| 24 May 2026 | Lipo-C FAT BLASTER | 7.0 A | 300mg/ml | 299.4mg/ml | -0.2% | 96.09% | l2a436 | Lab B | Community |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 5.8 B | 5mg | 5.8mg | +15.8% | 95.01% | 3cjbei | Lab F | Public |
| 24 May 2026 | MT-1 | 5.5 B | 2mg | 1.8mg | -9.7% | 95.89% | wba4u5 | Lab B | Community |
| 24 May 2026 | Proviron (Mesterolone) | 4.3 C | 25mg | 22.4mg | -10.6% | 98.12% | 376s5h | Lab D | Community |
| 24 May 2026 | ACE-031 | 5.2 B | 10mg | 12.5mg | +24.7% | 99.72% | sdz383 | Lab A | Public |
| 24 May 2026 | GHRP-6 Acetate | 7.6 A | 10mg | 10.2mg | +2.0% | 95.01% | tm027q | Lab B | Public |
| 24 May 2026 | Winstrol Oil | 4.7 C | 300mg/ml | 280.5mg/ml | -6.5% | 97.24% | 5ro2v4 | Lab F | Community |
| 23 May 2026 | BAC Water | 6.5 A | 50mg | 57.7mg | +15.3% | 96.07% | vbl00y | Lab F | Public |
| 23 May 2026 | GHRP-6 Acetate | 6.2 A | 2mg | 1.7mg | -14.5% | 99.46% | 987wqx | Lab E | Public |
| 23 May 2026 | Cortagen | 5.2 B | 30mg | 31.6mg | +5.4% | 97.30% | iyrdgh | Lab B | Community |
| 23 May 2026 | HMG | 8.5 A | 5mg | 4.9mg | -1.4% | 96.56% | lce4xp | Lab A | Public |
| 23 May 2026 | MT-1 | 5.5 B | 2mg | 2.4mg | +17.6% | 96.00% | dc0f7r | Lab D | Community |
| 21 May 2026 | BAC Water | 6.9 A | 30mg | 32.5mg | +8.5% | 98.88% | 8xu5e9 | Lab A | Public |
| 21 May 2026 | Primobolan E Raw | 6.3 A | 5g | 5.9g | +17.9% | 97.30% | 9my355 | Lab E | Community |
| 21 May 2026 | Semaglutide Oral | 4.5 C | 10mg | 11.1mg | +11.3% | 95.77% | 2leeoc | Lab D | Community |
| 21 May 2026 | Sustanon 400 | 4.0 C | 100mg/ml | 104.8mg/ml | +4.8% | 97.13% | ues5fg | Lab F | Community |
| 20 May 2026 | YK11 | 9.9 A | 25mg | 24.8mg | -1.0% | 95.51% | grho7p | Lab E | Public |
| 19 May 2026 | Aromasin (Exemestane) | 6.9 A | 10mg | 11.3mg | +12.9% | 99.62% | yuwiwg | Lab E | Public |
| 19 May 2026 | Ovagen | 7.4 A | 20mg | 19.6mg | -2.0% | 99.69% | gtjdzf | Lab B | Community |
| 17 May 2026 | BAC Water | 9.1 A | 2mg | 1.8mg | -7.5% | 97.56% | dyf37r | Lab F | Public |
| 17 May 2026 | Methylene Blue | 6.1 A | 10mg | 11.2mg | +11.6% | 98.50% | k0zx48 | Lab E | Public |
| 17 May 2026 | MOTS-C | 4.0 C | 20mg | 22.7mg | +13.7% | 96.38% | k8rwa4 | Lab F | Community |
| 29 Jan 2026 | Tesofensine | 5.7 B | 50mg | 45.0mg | -10.0% | 96.75% | eic1y1 | Lab G | Community |
| 26 Jan 2026 | Nitroethane CAS 79-24-3 | 8.3 A | 100g | 103.6g | +3.6% | 97.37% | es10oq | Lab G | Community |
| 26 Jan 2026 | S-23 Raw | 5.5 B | 500g | 584.0g | +16.8% | 99.84% | bhtpm8 | Lab G | Public |
| 19 Jan 2026 | Cortagen | 4.1 C | 30mg | 35.9mg | +19.6% | 97.20% | o3doiy | Lab E | Community |
| 19 Jan 2026 | GW-501516 (Cardarine) | 7.5 A | 10mg | 11.1mg | +10.9% | 97.21% | 86ca7i | Lab D | Community |
| 19 Jan 2026 | HMG | 8.6 A | 50mg | 57.9mg | +15.8% | 96.24% | fy0xvc | Lab A | Public |
| 19 Jan 2026 | MOTS-C | 7.9 A | 5mg | 5.0mg | +1.0% | 98.24% | qe9wj0 | Lab D | Public |
| 19 Jan 2026 | VIP | 4.0 C | 15mg | 14.8mg | -1.3% | 95.27% | qz6kph | Lab F | Public |
| 9 Jan 2026 | Cerebrolysin | 4.0 C | 30mg | 34.3mg | +14.3% | 99.67% | xv7my5 | Lab B | Public |
| 7 Jan 2026 | Equipoise (Boldenone Undecylenate) | 10.0 A | 250mg/ml | 264.3mg/ml | +5.7% | 95.80% | dmq0kv | Lab F | Community |
| 7 Jan 2026 | Equipoise (Boldenone Undecylenate) | 5.6 B | 300mg/ml | 313.4mg/ml | +4.5% | 97.11% | vyiikv | Lab A | Community |
| 7 Jan 2026 | Tren Hex | 5.6 B | 100mg/ml | 109.2mg/ml | +9.2% | 96.97% | n5l3qy | Lab C | Public |
| 7 Jan 2026 | YK11 | 6.5 A | 100mg | 89.1mg | -10.9% | 95.87% | dloo0e | Lab A | Public |
| 6 Jan 2026 | 4-AP (4-anilino-piperidine / N-phenyl-4-piperidinamine) CAS 23056-29-3 | 5.4 B | 5g | 4.6g | -7.1% | 95.69% | bymn7f | Lab E | Public |
| 6 Jan 2026 | BMK methyl glycidate CAS 80532-66-7 | 5.2 B | 100g | 95.8g | -4.2% | 95.53% | 4o4vyf | Lab A | Public |
| 6 Jan 2026 | Proviron (Mesterolone) | 4.0 C | 25mg | 28.3mg | +13.3% | 96.53% | vyeqcd | Lab C | Public |
| 29 Dec 2025 | Methylene Blue | 4.9 C | 10mg | 8.6mg | -14.2% | 95.91% | xvxs7u | Lab D | Community |
| 12 Dec 2025 | Boldenone Cypionate | 5.7 B | 300mg/ml | 302.4mg/ml | +0.8% | 96.89% | 9v1c4l | Lab E | Public |
| 12 Dec 2025 | GW-501516 (Cardarine) | 7.0 A | 25mg | 31.2mg | +24.6% | 99.51% | khzom5 | Lab A | Public |
| 12 Dec 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 4.3 C | 10mg | 8.6mg | -14.0% | 96.41% | db6r84 | Lab F | Community |
| 12 Dec 2025 | MT-1 | 6.3 A | 30mg | 34.6mg | +15.4% | 97.86% | kinq4f | Lab E | Public |
| 12 Dec 2025 | Ovagen | 5.7 B | 20mg | 22.4mg | +11.8% | 96.17% | soufi4 | Lab D | Public |
| 12 Dec 2025 | Tesofensine | 6.9 A | 20mg | 24.9mg | +24.7% | 99.06% | j1sxzv | Lab A | Public |
| 12 Dec 2025 | Winstrol Oil | 5.6 B | 200mg/ml | 186.8mg/ml | -6.6% | 97.02% | 4vo4vq | Lab E | Community |
| 5 Dec 2025 | ACE-031 | 6.1 A | 50mg | 50.4mg | +0.8% | 96.30% | 4tfi05 | Lab F | Public |
| 5 Dec 2025 | Boldenone Cypionate | 5.4 B | 200mg/ml | 218.0mg/ml | +9.0% | 96.26% | 2vda2c | Lab B | Community |
| 23 Nov 2025 | GW-501516 (Cardarine) | 4.8 C | 20mg | 18.1mg | -9.5% | 99.25% | no3kgo | Lab C | Public |
| 23 Nov 2025 | N-Acetyl Epitalon Amidate | 7.5 A | 5mg | 4.8mg | -3.3% | 95.04% | h2nupv | Lab B | Public |
| 17 Nov 2025 | CJC-1295 With DAC | 8.5 A | 50mg | 49.8mg | -0.4% | 99.62% | tn8fsq | Lab F | Public |
| 17 Nov 2025 | Metribolone | 5.2 B | 300mg/ml | 255.2mg/ml | -14.9% | 96.69% | kblug4 | Lab A | Public |
| 17 Nov 2025 | S-23 Raw | 5.5 B | 100g | 87.5g | -12.5% | 99.59% | f3uhhx | Lab C | Public |
| 14 Nov 2025 | Aromasin (Exemestane) | 8.0 A | 50mg | 50.1mg | +0.1% | 95.20% | ph1w6m | Lab C | Public |
| 5 Nov 2025 | Orforglipron | 6.6 A | 100mg | 97.5mg | -2.5% | 96.10% | lgx6rr | Lab E | Community |
| 5 Nov 2025 | Winstrol Oil | 4.5 C | 100mg/ml | 88.5mg/ml | -11.5% | 97.32% | yci8pk | Lab B | Public |
| 4 Nov 2025 | Ovagen | 6.1 A | 5mg | 5.0mg | -0.4% | 95.14% | 5gp4ye | Lab A | Public |
| 4 Nov 2025 | YK11 | 6.7 A | 100mg | 119.5mg | +19.5% | 99.33% | 4a882u | Lab F | Community |
| 17 Oct 2025 | Equipoise (Boldenone Undecylenate) | 9.6 A | 200mg/ml | 210.0mg/ml | +5.0% | 98.09% | r7eb1s | Lab F | Public |
| 17 Oct 2025 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 5.6 B | 50mg | 47.0mg | -6.0% | 97.89% | rc48uy | Lab B | Community |
| 17 Oct 2025 | Primobolan E Raw | 6.5 A | 500g | 516.2g | +3.2% | 95.37% | emswze | Lab F | Public |
| 9 Oct 2025 | EPO | 6.0 A | 30mg | 32.9mg | +9.6% | 95.13% | rxwv03 | Lab B | Community |
| 9 Oct 2025 | S-23 Raw | 5.8 B | 10g | 12.1g | +21.4% | 96.40% | gj6dn3 | Lab C | Community |
| 9 Oct 2025 | Semaglutide Oral | 6.5 A | 50mg | 60.8mg | +21.7% | 96.06% | vkarhm | Lab F | Public |
| 3 Oct 2025 | GHRP-6 Acetate | 5.7 B | 5mg | 5.1mg | +2.3% | 97.43% | 7pdxbl | Lab B | Public |
| 3 Oct 2025 | Metribolone | 6.9 A | 300mg/ml | 326.9mg/ml | +9.0% | 96.84% | rftugq | Lab G | Community |
| 3 Oct 2025 | Prostamax | 4.5 C | 2mg | 2.0mg | +1.1% | 98.77% | o1x14e | Lab A | Community |
| 21 May 2025 | Tirzepatide | X | 5.5 | 10mg | 10.7mg | +7.0% | 99.09% | Black Label / Silver Crimp / Red Cap | Lab D |
| 21 May 2025 | Semaglutide | X | 5.4 | 5mg | 5.4mg | +8.0% | 99.20% | Black Label / Silver Crimp / White Cap | Lab D |
| 21 May 2025 | Retatrutide | X | 4.0 | 5mg | 5.7mg | +14.0% | 99.12% | Black Label / Silver Crimp / Green Cap | Lab D |
| 20 May 2025 | CJC-1295 | No DAC X | 6.6 | 2mg | 2.02mg | +1.0% | 99.32% | Black Label / Silver Crimp / Purple Cap | Lab D |
| 20 May 2025 | Ipamorelin | X | 1.9 | 5mg | 6.27mg | +25.4% | 97.64% | Black Label / Silver Crimp / White Cap | Lab D |
| 5 May 2025 | BPC-157 | X | 5.8 | 5mg | 5.58mg | +11.6% | 99.80% | Black Label / Silver Crimp / Red Cap | Lab C |
| 2 May 2025 | BPC-157 | X | 5.4 | 5mg | 5.21mg | +4.2% | 98.38% | Black Label / Silver Crimp / Red Cap | Lab A |
— END OF EVIDENCE LOG —